Moment Of Truth For Eight New Drugs In EU

Mix Of Novel Treatments And Generics May Get Approval Recommendation

PTC Therapeutics’ gene therapy, eladocagene exuparvovec, and Sanofi’s enzyme replacement therapy, olipudase alfa, are among the latest products that the European Medicines Agency is considering for potential marketing approval.

Red stamp and an imprint EMA (European Medicines Agency) on white surface. EMA is an agency of the EU in charge of the evaluation and supervision
Drug sponsors could soon learn whether the EMA will endorse their products • Source: Alamy

More from Europe

More from Geography